treatment news

Black HIV-positive MSM in US still have lower rates of ART use

The proportion of newly diagnosed HIV-positive men who have sex with men (MSM) in the United States who were promptly linked to care and started antiretroviral therapy (ART) increased substantially between 2008 and 2014, investigators report in the online edition of...

read more

PrEP is approved in Scotland

The Scottish Medicines Consortium (SMC) today announced that it had accepted tenofovir disoproxil/emtricitabine (TDF/FTC – Truvada) for use within the Sottish National Health Service as pre-exposure prophylaxis (PrEP) to prevent HIV infection. It made the...

read more